Norman-Roberts syndrome

Lissencephaly 2, more commonly called Norman-Roberts syndrome, is a rare form of lissencephaly caused by a mutation in the reelin gene. Small number of cases have been described. The syndrome was first reported by M.Norman and M.Roberts et al. in 1976.^[1]

Product highlight

Streamlined Single-Use TFF Platform for Process Development Through Pilot Manufacturing

Continuous Low‑pH Virus Inactivation for Integrated Bioprocessing

Gentle Counterflow Centrifugation for Superior Cell Processing Results

Lack of reelin prevents normal layering of the cortex and disrupts cognitive development. Patients have cerebellar hypoplasia, they suffer from congenital lymphedema and hypotonia. The disorder is also associated with myopia, nystagmus, and generalized seizures.

Norman-Roberts syndrome is one of two known disorders caused by a disruption of reelin signaling pathway. The other is VLDLR-associated cerebellar hypoplasia, which is caused by a mutation in the gene coding for one of reelin receptors, VLDLR.

Disruption of RELN gene in human patients is analogous to the malfunctioning RELN gene in the reeler mouse.

References